REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,716,000 | -27.8% | 26,997 | +1.6% | 0.01% | -40.0% |
| Q2 2021 | $3,761,000 | -7.9% | 26,576 | -35.1% | 0.01% | -9.1% |
| Q1 2021 | $4,084,000 | +25.5% | 40,959 | +55.7% | 0.01% | +22.2% |
| Q4 2020 | $3,253,000 | +27.5% | 26,312 | +0.4% | 0.01% | 0.0% |
| Q3 2020 | $2,552,000 | -33.7% | 26,196 | +6.3% | 0.01% | -40.0% |
| Q2 2020 | $3,847,000 | +124.3% | 24,655 | +107.5% | 0.02% | +66.7% |
| Q1 2020 | $1,715,000 | -0.3% | 11,882 | +41.1% | 0.01% | 0.0% |
| Q4 2019 | $1,721,000 | +239.4% | 8,419 | +33.4% | 0.01% | +200.0% |
| Q3 2019 | $507,000 | -36.9% | 6,309 | -26.0% | 0.00% | -40.0% |
| Q2 2019 | $804,000 | +6.9% | 8,529 | -3.1% | 0.01% | 0.0% |
| Q1 2019 | $752,000 | – | 8,802 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |